Real World Data Estimation: Management and Cost-analysis of Stroke in Tertiary Hospitals in Turkey and the Impact of Co-morbid Malnutrition

Objective & Hypothesis:To evaluate the management and cost analysis of first-ever stroke patients in Turkey and determine the impact of comorbid malnutrition.

📊

Key Findings & Data:Results: Malnutrition was evident in 7.8(3.6)% [mean(standard error of mean; SEM)] of patients at admission; an additional 7.1(4.8)% and 0.9(0.6)% patients developed malnutrition during Neuro-ICU and stroke unit hospitalization, respectively.

💡

Conclusion & Impact:Length of hospital stay (LOS) was almost 2-fold in patients with malnutrition (P

🔬Design:Survey & Empirical Study

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

To evaluate the management and cost analysis of first-ever stroke patients in Turkey and determine the impact of comorbid malnutrition. Methods: This study was based on expert's view on the management and cost analysis of stroke patients with or without malnutrition via standardized questionnaire forms filled by experts according to their daily clinical practice. Cost items were related to medical treatment, healthcare resources utilization, tests, consultations and complications. Per admission and total annual direct medical costs were calculated with respect to co-morbid malnutrition. Results: Malnutrition was evident in 7.8(3.6)% [mean(standard error of mean; SEM)] of patients at admission; an additional 7.1(4.8)% and 0.9(0.6)% patients developed malnutrition during Neuro-ICU and stroke unit hospitalization, respectively. Length of hospital stay (LOS) was almost 2-fold in patients with malnutrition (P

Özet

Serebrovasküler olay nedeniyle ilk kez hastaneye başvuran hastalarda hastalık yönetimi ve maliyet analizini değerlendirerek, ko-morbid malnütrisyonun etkisini belirlemek. Yöntem: Bu çalışmada malnütrisyonu olan ve olmayan serebrovasküler olay tanılı hastalarda hastalık yönetimi ve maliyet analizine yönelik olarak uzman görüşleri, uzmanların günlük klinik pratikteki uygulamalarını yansıtacak şekilde doldurdukları standardize anket formları aracılığı ile belirlendi. Maliyet kalemlerini medikal tedavi, sağlık kaynakları kullanımı, testler, konsültasyonlar ve komplikasyonlar oluşturdu. Başvuru başına ve toplam yıllık doğrudan medikal maliyet ko-morbid malnütrisyon varlığına göre hesaplandı. Bulgular: Malnütrisyon başvuru esnasında hastaların %7.8(3.6) [ortalama (standart hata; SEM)]' sinde mevcut olup, ilave olarak hastaların %7.1(4.8) ve %0.9(0.6)' sı nörolojik yoğun bakım ve inme ünitesindeki yatışları esnasında malnütrisyon geliştirdi. Hospitalizasyon süresi malnütrisyonu olan hastalarda 2 kat daha uzun idi (P

🔖

Cite This Article

GÜNGÖR, L., YEŞİLOT, N., GİRAY, S., TOPÇUOĞLU, M. A., ÖZÇAĞLI, T. G., BERKTAŞ, M., SEYHUN, Ö., ULUÇ, K., YAKA, E., GÜLER, A., ÖZDEMİR, Ö., ARSAVA, E. M. (2022). Real World Data Estimation: Management and Cost-analysis of Stroke in Tertiary Hospitals in Turkey and the Impact of Co-morbid Malnutrition. Journal of Neurological Sciences (Turkish), Cilt: 33 - Sayı: 3, 443–458. https://ajindex.com/articles/564853

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (7)

Amarenco P, Labreuche J, Lavallée PC et al: Does ABCD2 score below 4 allow more time to evaluate patients with a transient ischemic attack? Stroke. 2009;40(9):3091-5. 2. Arenillas JF, Álvarez-Sabín J, Molina CA et al: C-Reactive Protein Predicts Further Ischemic Events in First-Ever Transient Ischemic Attack or Stroke Patients With Intracranial Large- Artery 2003;34(10):2463-8.
Stroke. Asimos AW, Johnson AM, Rosamond WD et al: A multicenter evaluation of the ABCD2 score's accuracy for predicting early ischemic stroke in admitted patients with transient ischemic attack. Ann Emerg Med 2010; 55(2): 201-10.
Ay H, Buonanno FS, Rordorf G et al: Normal diffusion-weighted MRI during stroke-like deficits. Neurology 1999; 52(9): 1784-92.
Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet 2000; 355(9211):1205-10. a double-blind Chandratheva A, Geraghty OC, Luengo- Fernandez R et al: ABCD2 score predicts severity rather than risk of early recurrent events after transient ischemic attack. Stroke 2010; 41(5): 851-6.
Chuang SY, Bai CH, Chen WH et al: Fibrinogen development of ischemic stroke in a Taiwanese population: CVDFACTS study. Stroke. 2009; 40(5): 10.1161/STROKEAHA.108.540492 19286580 Côté R, Wolfson C, Solymoss S et al: Hemostatic markers in patients at risk of cerebral ischemia. Stroke 2000; 31(8): 1856- 62. predicts the 1578-1584. doi: PMID: 8. Cucchiara BL, Messe SR, Sansing L et al: D- dimer, magnetic resonance imaging diffusion- weighted imaging, and ABCD2 score for transient ischemic attack risk stratification. J Stroke Cerebrovasc Dis. 2009;18(5):367-73.
Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke. An independent prognostic factor. Stroke. 2001;32(4):917-24.
Easton JD, Saver JL, Albers GW et al: Definition and evaluation of tranısient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke, 2009; 40: 2276-93 Council on Council on Periphera Edwards D, Cohn SR, Mavaddat N et al: Varying uses of the ABCD2 scorıi